$2.77
-0.01[-0.36%]
Last update: 9:27AM Get Real Time Here
Mereo BioPharma Group
(NASDAQ:MREO)Latest News for Mereo BioPharma Group Stock (NASDAQ:MREO)
Mereo BioPharma Group Stock (NASDAQ: MREO)
Categories: All
Monday, April 22, 2024
Wednesday, April 10, 2024
Thursday, March 28, 2024
- Mereo BioPharma shares are trading higher after the company reported a year-over-year increase in FY23 EPS results. Also, Needham maintained a Buy rating on the stock and raised its price target from $5 to $6.Benzinga Newsdesk - Mar 28, 2024, 12:35PM
- Cantor Fitzgerald Reiterates Overweight on Mereo BioPharma Group, Maintains $7 Price TargetBenzinga Newsdesk - Mar 28, 2024, 10:22AM
- Needham Maintains Buy on Mereo BioPharma Group, Raises Price Target to $6Benzinga Newsdesk - Mar 28, 2024, 6:05AM
Wednesday, March 27, 2024
Friday, March 22, 2024
Friday, January 26, 2024
Monday, January 08, 2024
Monday, October 23, 2023
Monday, October 16, 2023
- Why Is Mereo BioPharma Stock Trading Higher Today?Vandana Singh - Oct 16, 2023, 2:31PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Oct 16, 2023, 1:31PM
- Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Oct 16, 2023, 1:09PM
- Mereo BioPharma shares are trading higher after the company announced interim Phase 2 Data from the Phase 2/3 Orbit study demonstrating setrusumab significantly reduced fracture rates in patients with Osteogenesis Imperfecta.Benzinga Newsdesk - Oct 16, 2023, 11:23AM
- Reported Earlier, Ultragenyx And Mereo BioPharma Announced Interim Phase 2 Data From Phase 2/3 Orbit Study Demonstrating Setrusumab Significantly Reduced Fracture Rates In Patients With Osteogenesis ImperfectaBenzinga Newsdesk - Oct 16, 2023, 2:41AM
Monday, October 09, 2023
Friday, September 08, 2023
Thursday, September 07, 2023
Wednesday, August 23, 2023
Thursday, July 06, 2023
Wednesday, June 07, 2023
Tuesday, June 06, 2023
- High-Impact Movers for June 6thBenzinga Newsdesk - Jun 6, 2023, 8:37AM
- Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 6, 2023, 8:36AM
- Why Ultragenyx Pharma Stock Is Trading Higher Premarket TodayVandana Singh - Jun 6, 2023, 8:12AM
- Needham Reiterates Buy on Mereo BioPharma Group, Maintains $5 Price TargetBenzinga Newsdesk - Jun 6, 2023, 6:14AM